Cargando…

Interleukin-6 (IL-6) Receptor Antagonist Protects Against Rheumatoid Arthritis

BACKGROUND: The aim of this study was to investigate the protective effect of interleukin-6 (IL-6) receptor antagonist tocilizumab (TCZ) on rheumatoid arthritis (RA) and its related mechanism. MATERIAL/METHODS: Thirty RA patients receiving long-term methotrexate therapy at moderate and severe active...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Songsong, Wu, Zhenzhou, Li, Ling, Liu, Xuehua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2016
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920098/ https://www.ncbi.nlm.nih.gov/pubmed/27322646 http://dx.doi.org/10.12659/MSM.896355

Ejemplares similares

Interleukin 6 and Rheumatoid Arthritis
por: Yoshida, Yuji, et al.
Publicado: (2014)

Interleukin-6 in Rheumatoid Arthritis
por: Pandolfi, Franco, et al.
Publicado: (2020)

Structural Mimicry of Receptor Interaction by Antagonistic Interleukin-6 (IL-6) Antibodies
por: Blanchetot, Christophe, et al.
Publicado: (2016)

Interleukin-6 receptor in the recent-onset rheumatoid arthritis
por: Montes-Cano, Marco Antonio, et al.
Publicado: (2011)

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor
por: Dayer, Jean-Michel, et al.
Publicado: (2010)

Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells
Publicado: (1994)

Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
por: Robak, T, et al.
Publicado: (1998)

Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis
por: Favalli, Ennio G.
Publicado: (2020)

Cytochrome P450 activity in rheumatoid arthritis patients during continuous IL-6 receptor antagonist therapy
por: Dunvald, Ann-Cathrine Dalgård, et al.
Publicado: (2023)

IL-6 pathway-driven investigation of response to IL-6 receptor inhibition in rheumatoid arthritis
por: Wang, Jianmei, et al.
Publicado: (2013)

Serum Proteome Analysis in Patients with Rheumatoid Arthritis Receiving Therapy with Tocilizumab: An Anti-Interleukin-6 Receptor Antibody
por: Yanagida, Mitsuaki, et al.
Publicado: (2013)

Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
por: Hennigan, Stephanie, et al.
Publicado: (2008)

The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis
por: Hashizume, Misato, et al.
Publicado: (2011)

T-Cell Subsets in Rheumatoid Arthritis Patients on Long-Term Anti-TNF or IL-6 Receptor Blocker Therapy
por: Dulic, Sonja, et al.
Publicado: (2017)

Effectiveness and safety of the interleukin 6-receptor antagonist tocilizumab after 4 and 24 weeks in patients with active rheumatoid arthritis: the first phase IIIb real-life study (TAMARA)
por: Burmester, Gerd R, et al.
Publicado: (2010)

Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis
por: Kaczyński, Tomasz, et al.
Publicado: (2019)

Pathogenic roles of IL-6 and IL-6 blocking therapy on rheumatoid arthritis
por: Yoshizaki, K, et al.
Publicado: (2003)

CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis
por: Mahmood, Zafar, et al.
Publicado: (2015)

The Clinical Significance of Interleukin–1 Receptor Antagonist +2018 Polymorphism in Rheumatoid Arthritis
por: Ismail, Endom, et al.
Publicado: (2016)

Variation at interleukin-6 receptor gene is associated to joint damage in rheumatoid arthritis
por: Lopez-Lasanta, Maria, et al.
Publicado: (2015)

Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis
por: Choy, Ernest H S, et al.
Publicado: (2018)

Role of Interleukin 6 Inhibitors in the Management of Rheumatoid Arthritis
por: Yip, Ronald Man Lung, et al.
Publicado: (2021)

Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions
por: Smolen, Josef S, et al.
Publicado: (2013)

Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study
por: McInnes, Iain B, et al.
Publicado: (2015)

Recombinant human interleukin receptor antagonist influences serum chemokines in patients with rheumatoid arthritis
por: Bao, Jun, et al.
Publicado: (2014)

Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis
por: Almeida-Santiago, Cristina, et al.
Publicado: (2022)

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
por: Mihara, Masahiko, et al.
Publicado: (2011)

Body composition and serum levels of adiponectin, vascular endothelial growth factor, and interleukin-6 in patients with rheumatoid arthritis
por: Oranskiy, Sergey P., et al.
Publicado: (2012)

Interleukin 6/Wnt interactions in rheumatoid arthritis: interleukin 6 inhibits Wnt signaling in synovial fibroblasts and osteoblasts
por: Malysheva, Khrystyna, et al.
Publicado: (2016)

Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor
Publicado: (1990)

Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors
por: Frade-Sosa, Beatriz, et al.
Publicado: (2022)

Increase of Hemoglobin Levels by Anti-IL-6 Receptor Antibody (Tocilizumab) in Rheumatoid Arthritis
por: Hashimoto, Motomu, et al.
Publicado: (2014)

Correlations between serum interleukin 6, serum soluble interleukin 6 receptor, and disease activity in systemic juvenile idiopathic arthritis patients treated with or without tocilizumab
por: Vilaiyuk, Soamarat, et al.
Publicado: (2019)

Anti-Interleukin-6 Receptor Antibody Therapy-Induced Retinopathy in a Patient with Rheumatoid Arthritis
por: Tada, Asumi, et al.
Publicado: (2012)

Circulating interleukin-6 and rheumatoid arthritis: A Mendelian randomization meta-analysis
por: Li, Bing, et al.
Publicado: (2016)

Overnight variations in cortisol, interleukin 6, tumour necrosis factor α and other cytokines in people with rheumatoid arthritis
por: Perry, M G, et al.
Publicado: (2009)

Interleukin-6 Receptor Blockade Selectively Reduces IL-21 Production by CD4 T Cells and IgG4 Autoantibodies in Rheumatoid Arthritis
por: Carbone, Gustavo, et al.
Publicado: (2013)

The Effects of Gene Polymorphisms in Interleukin-4 and Interleukin-6 on the Susceptibility of Rheumatoid Arthritis in a Chinese Population
por: Li, Xiang, et al.
Publicado: (2014)

Development of Chronic Inflammatory Arthropathy Resembling Rheumatoid Arthritis in Interleukin 1 Receptor Antagonist–Deficient Mice
por: Horai, Reiko, et al.
Publicado: (2000)

Cathepsin S provokes interleukin-6 (IL-6) trans-signaling through cleavage of the IL-6 receptor in vitro
por: Flynn, Charlotte M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m8jf2a2iv2upu5m14krsdai5r3